Found: 19
Select item for more details and to access through your institution.
Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 5, p. 1, doi. 10.1093/ofid/ofae198
- By:
- Publication type:
- Article
Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: a retrospective study from the clinical practice.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality.
- Published in:
- Intensive Care Medicine, 2015, v. 41, n. 9, p. 1601, doi. 10.1007/s00134-015-3866-2
- By:
- Publication type:
- Article
Efficacy and Durability of Dolutegravir- or Darunavir-Based Regimens in ART-Naïve AIDS- or Late-Presenting HIV-Infected Patients.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 5, p. 1123, doi. 10.3390/v15051123
- By:
- Publication type:
- Article
Real-Life Impact of Drug Toxicity on Dolutegravir Tolerability: Clinical Practice Data from a Multicenter Italian Cohort.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 1, p. 163, doi. 10.3390/v14010163
- By:
- Publication type:
- Article
Shall We Dance? Extending TANGO's Results to Clinical Practice.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
Efficacy and durability of two‐ vs. three‐drug integrase inhibitor‐based regimens in virologically suppressed HIV‐infected patients: Data from real‐life ODOACRE cohort.
- Published in:
- HIV Medicine, 2021, v. 22, n. 9, p. 843, doi. 10.1111/hiv.13146
- By:
- Publication type:
- Article
'How much raltegravir do you take?' The answer may not be so obvious: an accidental finding from clinical practice.
- Published in:
- HIV Medicine, 2020, v. 21, n. 2, p. e1, doi. 10.1111/hiv.12783
- By:
- Publication type:
- Article
Case Report: Multifocal Tubercular Osteomyelitis of the Spine and Bilateral Dactylitis.
- Published in:
- American Journal of Tropical Medicine & Hygiene, 2019, v. 101, n. 3, p. 494, doi. 10.4269/ajtmh.19-0262
- By:
- Publication type:
- Article
Seroprevalence of SARS-CoV-2 Antibodies in HIV-Infected Patients in Rome, Italy during the COVID-19 Outbreak.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 7, p. 1154, doi. 10.3390/diagnostics11071154
- By:
- Publication type:
- Article
EFFICACY OF 3TC+DTG VS 3-DRUG REGIMENS IN VIROLOGICALLYSUPPRESSED PLWH.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 227
- By:
- Publication type:
- Article
Toxoplasmosis mimicking CMV chorioretinitis in newly diagnosed PLWH: a case report.
- Published in:
- Infezioni in Medicina, 2023, v. 31, n. 3, p. 404, doi. 10.53854/liim-3103-15
- By:
- Publication type:
- Article
Single tablet regimen with abacavir/lamivudine/dolutegravir compared with two-drug regimen with lamivudine and dolutegravir as different strategies of simplification from a multicenter HIV cohort study.
- Published in:
- Infezioni in Medicina, 2019, v. 27, n. 4, p. 410
- By:
- Publication type:
- Article
Changes in bone mineral density in HIV-positive, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy: preliminary results from clinical practice.
- Published in:
- Infezioni in Medicina, 2018, v. 26, n. 4, p. 336
- By:
- Publication type:
- Article
Are we really ready for dual therapy in naive people with HIV? The experience from a large university hospital in Rome, Italy.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 2, p. 473, doi. 10.1093/jac/dkad405
- By:
- Publication type:
- Article
Comment on: Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 7, p. 1808, doi. 10.1093/jac/dkad151
- By:
- Publication type:
- Article
Efficacy and safety of raltegravir in switch strategies in virologically suppressed patients: long-term data from clinical practice.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Virological efficacy of dual therapy with lamivudine and dolutegravir in HIV-1-infected virologically suppressed patients: long-term data from clinical practice.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Systemic inflammation markers after simplification to atazanavir/ritonavir plus lamivudine in virologically suppressed HIV-1-infected patients: ATLAS-M substudy.
- Published in:
- 2018
- By:
- Publication type:
- journal article